CML-iPSCs expressed significantly higher levels of AVCR1 (ALK2) and BMPR1A (ALK3) receptors than normal iPSCs, with high levels of BMPR1B (ALK6) expressed by both (Fig. 6d–i). The gene discussed is BMPR1B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.